BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2463121)

  • 1. Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia.
    Engbaek F; Christensen SE; Jespersen B
    Clin Chem; 1989 Jan; 35(1):93-7. PubMed ID: 2463121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hemoglobin A1C immunoassay method not affected by carbamylated hemoglobin.
    Rose AM; Tongate C; Valdes R
    Ann Clin Lab Sci; 1995; 25(1):13-9. PubMed ID: 7762964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of carbamylated hemoglobin by high-performance liquid chromatography.
    Kwan JT; Carr EC; Bending MR; Barron JL
    Clin Chem; 1990 Apr; 36(4):607-10. PubMed ID: 2323040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
    Mácsai E; Rakk E; Miléder M; Fulcz A
    Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three assay systems for automated determination of hemoglobin A1c.
    Halwachs-Baumann G; Katzensteiner S; Schnedl W; Pürstner P; Pieber T; Wilders-Truschnig M
    Clin Chem; 1997 Mar; 43(3):511-7. PubMed ID: 9068596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemoglobin A1c in patients under periodic hemodialysis or continuous ambulatory peritoneal dialysis].
    Blumberg A; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(7):208-11. PubMed ID: 3952477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term glycemic control measurements in diabetic patients receiving hemodialysis.
    Joy MS; Cefalu WT; Hogan SL; Nachman PH
    Am J Kidney Dis; 2002 Feb; 39(2):297-307. PubMed ID: 11840370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated and carbamylated haemoglobin in uraemia.
    Smith WG; Holden M; Benton M; Brown CB
    Nephrol Dial Transplant; 1989; 4(2):96-100. PubMed ID: 2496361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay.
    Weykamp CW; Penders TJ; Siebelder CW; Muskiet FA; van der Slik W
    Clin Chem; 1993 Jan; 39(1):138-42. PubMed ID: 8419039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific affinity-chromatographic measurement of glycated hemoglobins in uremic patients.
    Bruns DE; Lobo PI; Savory J; Wills MR
    Clin Chem; 1984 Apr; 30(4):569-71. PubMed ID: 6705201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylated haemoglobin (HbA1) in renal failure.
    Patnaik BC; Patnaik SR; Mahakur AC; Tripathy UC; Sahu H; Misra SC
    J Assoc Physicians India; 1987 May; 35(5):360-2. PubMed ID: 3693288
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoturbidimetric assay of glycated hemoglobin.
    Metus P; Ruzzante N; Bonvicini P; Meneghetti M; Zaninotto M; Plebani M
    J Clin Lab Anal; 1999; 13(1):5-8. PubMed ID: 10025731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamylated haemoglobin in chronic renal failure.
    Smith WG; Holden M; Benton M; Brown CB
    Clin Chim Acta; 1988 Dec; 178(3):297-303. PubMed ID: 3240603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure.
    Davenport A; Jones S; Goel S; Astley JP; Feest TG
    Kidney Int; 1996 Oct; 50(4):1344-51. PubMed ID: 8887297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic evaluation of minor hemoglobins: clinical significance of hemoglobin A1d, comparison with hemoglobin A1c, and possible interferences.
    Bissé E; Huaman-Guillen P; Wieland H
    Clin Chem; 1995 May; 41(5):658-63. PubMed ID: 7729042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of Hb A1c in chronic renal failure. Contribution of new methodologies].
    Flory E; Marzullo C; Bourderont D; Genestier S; Marichal B; Parent X
    Ann Biol Clin (Paris); 1996; 54(5):211-4. PubMed ID: 8869361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor haemoglobin fractions in uraemic and in diabetic patients.
    Lantz B; Wajcman H; Beaufils M; Meyrier A; Labie D; Assan R
    Diabete Metab; 1981 Jun; 7(2):109-14. PubMed ID: 6788617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis.
    Bendersky VA; Mulvihill MS; Yerokun BA; Ezekian B; Davis RP; Hartwig MG; Barbas AS
    Exp Clin Transplant; 2019 Oct; 17(5):613-618. PubMed ID: 30674242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycosylated hemoglobin in chronic renal insufficiency].
    Grassi R; Macchia M; Dazzi F
    Minerva Med; 1981 Feb; 72(4-5):233-6. PubMed ID: 7207846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.